Inflammatory Intestinal Diseases - East Meets West - An Integrative Approach - Karger Publishers
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
6 | 2 | 21 Inflammatory Intestinal Diseases East Meets West – An Integrative Approach
Relevant information
close to you
Become more efficient with the AI-based
discovery tool
* Karger Publishers collaborates with the award-winning
analytics ctompany Quertle to support in the task of
curation. The Artificial Intelligence (AI)-based discovery
tool Qinsight simplifies the research process.
KI20249
Inflammatory
Intestinal
Diseases
Editors-in-Chief
Gerhard Rogler – University Hospital, Zurich, Switzerland
Toshifumi Hibi – Kitasato University, Tokyo, Japan
Associate Editors
Affiliated with Silvio Danese – Humanitas University, Rozzano (MI), Italy
Hans Herfarth – University of North Carolina, Chapel Hill, NC, USA
Beat Müllhaupt – University Hospital, Zurich, Switzerland
Masakazu Nagahori – Tokyo Medical and Dental University, Medical Hospital, Tokyo,
Japan
Choon Jin Ooi – Gleneagles Medical Centre, Singapore, Singapore
Zhihua Ran – Shanghai Jiao Tong University, Shanghai, China
Dario Sorrentino – Virginia Tech – Carilion School of Medicine, Roanoke, VA, USA
Stephan Vavricka – Zentrum für Gastroenterologie und Hepatologie, Zurich,
Switzerland
Kenji Watanabe – Hyogo College of Medicine, Nishinomiya, Japan
Mamoru Watanabe – Tokyo Medical and Dental University, Tokyo, Japan
Gillian Watermeyer – Groote Schuur Hospital and University of Cape Town, Cape Town,
South Africa
Ming-Shiang Wu – National Taiwan University, Taipei, Taiwan
Suk-Kyun Yang – University of Ulsan College of Medicine, Seoul, Korea
Editorial Board
Andre G. Buret – University of Calgary, Calgary, AB, Canada
Jae Hee Cheon – Yonsei University College of Medicine, Seoul, Korea
Andrew S. Day – University of Otago, Christchurch, New Zealand
Devendra Desai – P.D. Hinduja National Hospital & Medical Research Centre Veer
Savarkar Marg, Mumbai, India
Iris Dotan – Beilinson Hospital , Petah Tikva, Israel
Richard Gearry – Department of Medicine University of Otago, Christchurch,
New Zealand
Tadakazu Hisamatsu – Kyorin University School of Medicine, Tokyo, Japan
Pin-Jin Hu – Sun Yat Sen University, Guangzhou, China
Arthur Kaser – University of Cambridge, Cambridge, UK
Lawrence Khek-Yu Ho – National University, Singapore, Singapore
Taku Kobayashi – Kitasato University, Tokyo, Japan
(Continued on next page)
Printed in Germany on acid-free and non-aging paper
(ISO 9706) by Stückle Druck, Ettenheim
(Continued)
Kaija-Leena Kolho – University of Helsinki, Helsinki, Finland
John Tsung-Chun Lee – National Taiwan University, Taipei City, Taiwan
Ling Khoon Lin – Singapore General Hospital, Singapore, Singapore
Toshiyuki Matsui – Fukuoka University Chikushi Hospital, Fukuoka, Japan
Katsuyoshi Matsuoka – Toho University Sakura Medical Center, Sakura, Japan
Hiroshi Nakase – Sapporo Medical University School of Medicine, Sapporo, Japan
Siew C. Ng – Chinese University of Hong Kong, Hong Kong, China
Jiaming Qian – Peking Union Medical College Hospital, Peking, China
Michael Scharl – University Hospital Zurich, Zurich, Switzerland
Ala Sharara – American University of Beirut Medical Center, Beirut, Lebanon
Shinichiro Shinzaki – Osaka University Medical School, Suita, Japan
Flavio Steinwurz – Hospital Israelita Albert Einstein, Sao Paulo, Brazil
Yasuo Suzuki – Toho University Medical Center Sakura Hospital, Chiba, Japan
Tomohisa Takagi – Kyoto Prefectural University of Medicine, Kyoto, Japan
Byong Duk Ye – Asan Medical Center, Seoul, Korea
Linda Chia-Hui Yu – National Taiwan University College of Medicine, Taipei, Taiwan
Qing Zheng – Shanghai Jiao Tong University School of Medicine, Shanghai, China
© 2021 S. Karger AG, Basel
www.karger.com
karger@karger.com
Journal Information
Aims and Scope
Imparting the most current information to physicians caring for patients with intestinal dis-
eases, this journal seeks to identify the basic pathophysiological mechanisms common to
different inflammatory intestinal diseases, to compare the environmental conditions in-
volved in their pathogenesis, and to provide important insights into their therapies. Inflam-
matory Intestinal Diseases thus reduces the gap between clinical and basic sciences as well
Guidelines for Authors as between hepatology and inflammatory diseases of the intestinal tract such as inflamma-
We strongly encourage authors to read
the Guidelines for Authors at
tory bowel diseases, celiac disease and irritable bowel syndrome.
www.karger.com/iid_guidelines prior to Inflammatory Intestinal Diseases also aims to improve the exchange of knowledge between
submitting an article. researchers from Eastern and Western countries, which is reflected in the composition of the
Editorial Board. The journal accepts randomized controlled clinical trials, observational stud-
ies, and cost-effectiveness analyses as well as commentary type and systematic reviews and
consensus statements.
Journal Contact
For questions or comments, please contact
the persons responsible who can be found at
http://www.karger.com/Journal/Contact/261895.
ISSN Print Edition: 2296–9403 Disclaimer: The statements, opinions and data con-
ISSN Online Edition: 2296–9365 tained in this publication are solely those of the indi-
vidual authors and contributors and not of the pub-
Journal Homepage: www.karger.com/iid lisher and the editor(s). The appearance of advertise-
Bibliographic Indices: This journal is regularly l isted ments in the journal is not a warranty, endorsement,
in bibliographic services, including PubMed/PubMed or approval of the products or services advertised or
Central. of their effectiveness, quality or safety. The publisher
and the editor(s) disclaim responsibility for any injury
Publication Data: Inflammatory Intestinal Diseases to persons or property resulting from any ideas,
is published 4 times a year. Volume 6 with 4 issues, methods, instructions or products referred to in the
appears in 2021. content or advertisements.
Copyright: © 2021 S. Karger AG, Basel (Switzerland).
All rights reserved. No part of this publication may be
translated into other languages, reproduced or uti-
lized in any form or by any means, electronic or me-
chanical, including photocopying, recording, micro-
copying, or by any information storage and retrieval
system, without permission in writing from the pub-
lisher.
© 2021 S. Karger AG, Basel
www.karger.com
karger@karger.com
Vol. 6, No. 2, 2021
Contents
Research Articles
61 Physical Activity in Patients with Inflammatory Bowel Disease:
A Cross-Sectional Study
Fagan, G.; Osborne, H.; Schultz, M. (Dunedin)
70 Real-World Experience of Endoscopic Submucosal Dissection for Ulcerative
Colitis-Associated Neoplasia
Matsui, A.; Hoteya, S.; Hayasaka, J.; Yamashita, S.; Ochiai, Y.; Suzuki, Y.; Fukuma, Y.; Okamura, T.;
Mitsunaga, Y.; Tanaka, M.; Nomura, K.; Dan, N.; Odagiri, H.; Kikuchi, D. (Tokyo)
78 What Are the Most Challenging Aspects of Inflammatory Bowel Disease?
An International Survey of Gastroenterologists Comparing Developed and
Developing Countries
Gearry, R.B.; McCombie, A.M. (Christchurch); Vatn, M. (Oslo); Rubin, D.T. (Chicago, IL); Steinwurz, F.
(Sao Paulo); Loftus, E.V. (Rochester, MN); Kruis, W. (Cologne); Tysk, C. (Orebro); Colombel, J.-F.
(New York, NY); Ng, S.C. (Hong Kong); Van Assche, G. (Leuven); Bernstein, C.N. (Winnipeg, MB)
87 Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal Mucosa
Simmen, S.; Maane, M.; Rogler, S.; Baebler, K.; Lang, S.; Cosin-Roger, J.; Atrott, K.; Frey-Wagner, I.;
Spielmann, P.; Wenger, R.H.; Weder, B.; Zeitz, J.; Vavricka, S.R.; Rogler, G.; de Vallière, C.; Hausmann, M.;
Ruiz, P.A. (Zurich)
101 Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy:
Does It Matter in Clinical Practice? A Retrospective Observational Study
Hovstadius, H.; Lundgren, D.; Karling, P. (Umeå)
109 Faecal Inflammatory Biomarkers and Gastrointestinal Symptoms after
Bariatric Surgery: A Longitudinal Study
Westerink, F.; Huibregtse, I. (Amsterdam); De Hoog, M.; Bruin, S.; Meesters, E. (Hoofddorp); Brandjes, D.
(Amsterdam); Gerdes, V. (Amsterdam/Hoofddorp)
117 Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in
Patients with Ulcerative Colitis
Yoshida, A. (Kamakura); Matsuoka, K. (Chiba); Ueno, F.; Morizane, T.; Endo, Y. (Kamakura); Hibi, T.
(Tokyo)
Cover illustration
© iStock.com
© 2021 S. Karger AG, Basel
Access to full text and tables of contents,
including tentative ones for forthcoming issues:
www.karger.com/iidFast Facts:
Inflammatory Bowel Disease
6
FAST FACTS
nowledge, fast!
SIXTH
EDITION
e medical handbook series
Inflammatory
FREE
Inflammatory Bowel Disease
Bowel Disease
ase ACCESS
cations
David S Rampton and Fergus Shanahan
mplications
litis
ase
age
SIXTH EDITION
ISBN 978-3-318-06655-5
Translating the science into compassionate IBD care
9 783318 066555
IA21015
karger.com/fastfacts
HEALTHCAREHealthcare products
and services by Karger.
For clinicians, patients,
and caregivers.
KI20248You have the research –
now let the world know.
Publish with Karger.
SUBMIT
NOW
IA21010
https://www.karger.com/calls-for-papersYou can also read
